Literature DB >> 19521670

Alternative Fas-mediated cell death pathway is dependent on the different cleavage patterns of procaspase-8.

Yufeng Li1, Lei Qi, Atsushi Iwao, Kentaro Kihira, Francis Dida, Zhenhu Song, Eiichi Azuma, Yoshihiro Komada.   

Abstract

It has been reported that mitochondria-independent or mitochondria-dependent (type I/II) Fas signaling pathways in leukemia cells depend on the amount of active caspase-8. However, Bid molecules, which could not be cleaved in type I cells, could be effectively cleaved by recombinant active caspase-8 in vitro. The cleavage of recombinant Bid by recombinant active caspase-8 could be blocked by anti-p10 and anti-p18 specific antibodies. Fas receptors could be similarly internalized into cytoplasm in type I and type II cells. Interestingly, p10 subunit of active caspase-8 could be detected in both type I and II cells, while p18 subunit of active caspase-8 could be detected only in type II cells but not in type I cells. These results demonstrated that p18 subunit was necessary for Bid cleavage and the mitochondria pathway might be dependent on the release of p18 subunit from active caspase-8.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521670     DOI: 10.1007/s11010-009-0164-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  Cardiolipin provides specificity for targeting of tBid to mitochondria.

Authors:  M Lutter; M Fang; X Luo; M Nishijima; X Xie; X Wang
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

2.  The active caspase-8 heterotetramer is formed at the CD95 DISC.

Authors:  I Lavrik; A Krueger; I Schmitz; S Baumann; H Weyd; P H Krammer; S Kirchhoff
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

3.  The role of receptor internalization in CD95 signaling.

Authors:  Kyeong-Hee Lee; Christine Feig; Vladimir Tchikov; Robert Schickel; Cora Hallas; Stefan Schütze; Marcus E Peter; Andrew C Chan
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

4.  FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.

Authors:  A M Chinnaiyan; K O'Rourke; M Tewari; V M Dixit
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

5.  FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

Authors:  J P Medema; C Scaffidi; F C Kischkel; A Shevchenko; M Mann; P H Krammer; M E Peter
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

6.  Two CD95 (APO-1/Fas) signaling pathways.

Authors:  C Scaffidi; S Fulda; A Srinivasan; C Friesen; F Li; K J Tomaselli; K M Debatin; P H Krammer; M E Peter
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

7.  Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression.

Authors:  Silvia Cursi; Alessandra Rufini; Venturina Stagni; Ivano Condò; Vittoria Matafora; Angela Bachi; Antonio Paniccià Bonifazi; Luigi Coppola; Giulio Superti-Furga; Roberto Testi; Daniela Barilà
Journal:  EMBO J       Date:  2006-04-13       Impact factor: 11.598

8.  Interdimer processing mechanism of procaspase-8 activation.

Authors:  David W Chang; Zheng Xing; Vanessa L Capacio; Marcus E Peter; Xiaolu Yang
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

9.  Caspase-8 goes cardiolipin: a new platform to provide mitochondria with microdomains of apoptotic signals?

Authors:  Luca Scorrano
Journal:  J Cell Biol       Date:  2008-11-10       Impact factor: 10.539

10.  Cardiolipin provides an essential activating platform for caspase-8 on mitochondria.

Authors:  Francois Gonzalvez; Zachary T Schug; Riekelt H Houtkooper; Elaine D MacKenzie; David G Brooks; Ronald J A Wanders; Patrice X Petit; Frédéric M Vaz; Eyal Gottlieb
Journal:  J Cell Biol       Date:  2008-11-10       Impact factor: 10.539

View more
  1 in total

1.  p62 aggregates mediated Caspase 8 activation is responsible for progression of ovarian cancer.

Authors:  Xiao-Yu Yan; Xin-Ru Zhong; Si-Hang Yu; Li-Chao Zhang; Ya-Nan Liu; Yong Zhang; Lian-Kun Sun; Jing Su
Journal:  J Cell Mol Med       Date:  2019-04-02       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.